ALS has 26 subtypes, with FUS being a biomarker for type 6, SOD1 for type 1, and TARDBP for type 10, suggesting that the patients in the study may represent a mixture of these ALS subtypes. Here, SOD1 is linked to amyotrophic lateral sclerosis.